Tiger BufordYour Orthopedic Industry Expert (free today)

BoneChat #16 short - The "Miss" in Clinical Trials - Patrick Reischling

3 Apr 2024 · 0 min

Watch on YouTube

0:29

Patrick Reischling explains why clinical trials often miss collecting operative time and other data crucial for coding and reimbursement. Trial designers should capture these metrics from the start instead of scrambling to justify coverage decisions later.

You know, did you collect your operative time? You know, you're reducing operative. So it's important to have the conversations on what may be some important data points to help you in your coding and coverage arguments down the road before you even start into it. And that's one of the biggest areas where I see a miss is that big trials get put underway for a specific use like FDA approval without also thinking about what also can you get out of this trial that can help with coding and coverage.

More from Tiger

1:00:35

BoneChat #146 - Raising Capital, Protecting Equity, Dilution & Staying Lean

1w ago

58:35

BoneChat #145 - ASC Robots, Direct-to-Patient Marketing & Ortho Startup Reality

2w ago

57:20

BoneChat #144 - Defining the Standard of Care for Orthopedic Tissue Preservation & Restoration

4w ago

56:40

BoneChat #143 - AI-Driven MedTech Sales, Startup Traps, & Orthopedic Commercialization

1mo ago

1:20

Reverse Shoulder movement in the US

1mo ago

1:03:29

BoneChat #142 - Fastest-Growing Ortho Segments, Reverse Shoulder & Joint Preservation Rollups

1mo ago

59:10

BoneChat #141 - Disrupting Surgical Visualization: Single-Use 4K Scopes with Richard McKillop

1mo ago

57:56

BoneChat #140 - Transforming Knee Rehab, Patient Experience, and MedTech Go-to-Market

1mo ago

0:36

How to find early adopters in Ortho.

2mo ago

0:35

The Importance of Controlling Your Own Destiny in Deals

2mo ago

0:50

Red Flags in Business Partnerships

2mo ago

See all content